Quantitative US for Hepatic Steatosis
Diagnostic Value of Quantitative Ultrasound Imaging Parameters for Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease
Sponsor: Samsung Medison
Listed as NCT04180631, this NA trial focuses on Hepatic Steatosis and remains completed. Sponsored by Samsung Medison, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Sep 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Dec 2019 — Apr 2020 [monthly]
Recruiting NA
First recorded
Mar 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Samsung Medison
- Seoul National University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .